145 related articles for article (PubMed ID: 12439223)
21. Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling.
Collins BN; Wileyto EP; Patterson F; Rukstalis M; Audrain-McGovern J; Kaufmann V; Pinto A; Hawk L; Niaura R; Epstein LH; Lerman C
Nicotine Tob Res; 2004 Feb; 6(1):27-37. PubMed ID: 14982685
[TBL] [Abstract][Full Text] [Related]
22. Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial.
Lerman C; Shields PG; Wileyto EP; Audrain J; Hawk LH; Pinto A; Kucharski S; Krishnan S; Niaura R; Epstein LH
Health Psychol; 2003 Sep; 22(5):541-8. PubMed ID: 14570538
[TBL] [Abstract][Full Text] [Related]
23. Drugs and genotypes: how pharmacogenetic information could improve smoking cessation treatment.
Lee AM; Tyndale RF
J Psychopharmacol; 2006 Jul; 20(4 Suppl):7-14. PubMed ID: 16785264
[TBL] [Abstract][Full Text] [Related]
24. Determinants of the rate of nicotine metabolism and effects on smoking behavior.
Johnstone E; Benowitz N; Cargill A; Jacob R; Hinks L; Day I; Murphy M; Walton R
Clin Pharmacol Ther; 2006 Oct; 80(4):319-30. PubMed ID: 17015050
[TBL] [Abstract][Full Text] [Related]
25. A placebo controlled trial of bupropion for smoking cessation in schizophrenia.
George TP; Vessicchio JC; Termine A; Bregartner TA; Feingold A; Rounsaville BJ; Kosten TR
Biol Psychiatry; 2002 Jul; 52(1):53-61. PubMed ID: 12079730
[TBL] [Abstract][Full Text] [Related]
26. Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation.
Leventhal AM; David SP; Brightman M; Strong D; McGeary JE; Brown RA; Lloyd-Richardson EE; Munafò M; Uhl GR; Niaura R
Pharmacogenomics J; 2012 Feb; 12(1):86-92. PubMed ID: 20661272
[TBL] [Abstract][Full Text] [Related]
27. Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study.
Tonstad S; Farsang C; Klaene G; Lewis K; Manolis A; Perruchoud AP; Silagy C; van Spiegel PI; Astbury C; Hider A; Sweet R
Eur Heart J; 2003 May; 24(10):946-55. PubMed ID: 12714026
[TBL] [Abstract][Full Text] [Related]
28. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
[TBL] [Abstract][Full Text] [Related]
29. Influence of CYP2B6 genetic variants on plasma and urine concentrations of bupropion and metabolites at steady state.
Benowitz NL; Zhu AZ; Tyndale RF; Dempsey D; Jacob P
Pharmacogenet Genomics; 2013 Mar; 23(3):135-41. PubMed ID: 23344581
[TBL] [Abstract][Full Text] [Related]
30. A bupropion smoking cessation clinical trial for cancer patients.
Schnoll RA; Martinez E; Tatum KL; Weber DM; Kuzla N; Glass M; Ridge JA; Langer C; Miyamoto C; Wileyto EP; Leone F
Cancer Causes Control; 2010 Jun; 21(6):811-20. PubMed ID: 20087643
[TBL] [Abstract][Full Text] [Related]
31. Sustained-release bupropion for hospital-based smoking cessation: a randomized trial.
Simon JA; Duncan C; Huggins J; Solkowitz S; Carmody TP
Nicotine Tob Res; 2009 Jun; 11(6):663-9. PubMed ID: 19395688
[TBL] [Abstract][Full Text] [Related]
32. Pharmacogenetic Influence on Stereoselective Steady-State Disposition of Bupropion.
Kharasch ED; Lenze EJ
Drug Metab Dispos; 2024 Apr; 52(5):455-466. PubMed ID: 38467432
[TBL] [Abstract][Full Text] [Related]
33. Bupropion for smoking cessation: a randomized trial.
Simon JA; Duncan C; Carmody TP; Hudes ES
Arch Intern Med; 2004 Sep; 164(16):1797-803. PubMed ID: 15364675
[TBL] [Abstract][Full Text] [Related]
34. Bupropion for smoking cessation in patients hospitalized with acute myocardial infarction: a randomized, placebo-controlled trial.
Eisenberg MJ; Grandi SM; Gervais A; O'Loughlin J; Paradis G; Rinfret S; Sarrafzadegan N; Sharma S; Lauzon C; Yadav R; Pilote L;
J Am Coll Cardiol; 2013 Feb; 61(5):524-32. PubMed ID: 23369417
[TBL] [Abstract][Full Text] [Related]
35. [Smoking cessation: Pharmacological strategies different from standard treatments].
Underner M; Perriot J; Peiffer G; Harika-Germaneau G; Jaafari N
Rev Pneumol Clin; 2018 Sep; 74(4):205-214. PubMed ID: 29773262
[TBL] [Abstract][Full Text] [Related]
36. Sustained-release bupropion for smoking cessation in a Chinese sample: a double-blind, placebo-controlled, randomized trial.
Sheng LX; Tang YL; Jiang ZN; Yao CH; Gao JY; Xu GZ; Tong XY
Nicotine Tob Res; 2013 Feb; 15(2):320-5. PubMed ID: 22614545
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
[TBL] [Abstract][Full Text] [Related]
38. Targeting smokers at increased risk for relapse: treating women and those with a history of depression.
Smith SS; Jorenby DE; Leischow SJ; Nides MA; Rennard SI; Johnston JA; Jamerson B; Fiore MC; Baker TB
Nicotine Tob Res; 2003 Feb; 5(1):99-109. PubMed ID: 12745511
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism.
Hayford KE; Patten CA; Rummans TA; Schroeder DR; Offord KP; Croghan IT; Glover ED; Sachs DP; Hurt RD
Br J Psychiatry; 1999 Feb; 174():173-8. PubMed ID: 10211174
[TBL] [Abstract][Full Text] [Related]
40. Bupropion and cognitive-behavioral treatment for depression in smoking cessation.
Brown RA; Niaura R; Lloyd-Richardson EE; Strong DR; Kahler CW; Abrantes AM; Abrams D; Miller IW
Nicotine Tob Res; 2007 Jul; 9(7):721-30. PubMed ID: 17577801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
